161 related articles for article (PubMed ID: 29964122)
1. Inhalable multi-compartmental phospholipid enveloped lipid core nanocomposites for localized mTOR inhibitor/herbal combined therapy of lung carcinoma.
Kabary DM; Helmy MW; Abdelfattah EA; Fang JY; Elkhodairy KA; Elzoghby AO
Eur J Pharm Biopharm; 2018 Sep; 130():152-164. PubMed ID: 29964122
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronate/lactoferrin layer-by-layer-coated lipid nanocarriers for targeted co-delivery of rapamycin and berberine to lung carcinoma.
Kabary DM; Helmy MW; Elkhodairy KA; Fang JY; Elzoghby AO
Colloids Surf B Biointerfaces; 2018 Sep; 169():183-194. PubMed ID: 29775813
[TBL] [Abstract][Full Text] [Related]
3. Targeting sialic acid residues on lung cancer cells by inhalable boronic acid-decorated albumin nanocomposites for combined chemo/herbal therapy.
Elgohary MM; Helmy MW; Abdelfattah EA; Ragab DM; Mortada SM; Fang JY; Elzoghby AO
J Control Release; 2018 Sep; 285():230-243. PubMed ID: 30009892
[TBL] [Abstract][Full Text] [Related]
4. Inhalable lactoferrin-chondroitin nanocomposites for combined delivery of doxorubicin and ellagic acid to lung carcinoma.
Abd Elwakil MM; Mabrouk MT; Helmy MW; Abdelfattah EA; Khiste SK; Elkhodairy KA; Elzoghby AO
Nanomedicine (Lond); 2018 Aug; 13(16):2015-2035. PubMed ID: 30191764
[TBL] [Abstract][Full Text] [Related]
5. Inhalable Lactoferrin/Chondroitin-Functionalized Monoolein Nanocomposites for Localized Lung Cancer Targeting.
Abdelaziz HM; Elzoghby AO; Helmy MW; Abdelfattah EA; Fang JY; Samaha MW; Freag MS
ACS Biomater Sci Eng; 2020 Feb; 6(2):1030-1042. PubMed ID: 33464839
[TBL] [Abstract][Full Text] [Related]
6. Self-assembled amphiphilic zein-lactoferrin micelles for tumor targeted co-delivery of rapamycin and wogonin to breast cancer.
Sabra SA; Elzoghby AO; Sheweita SA; Haroun M; Helmy MW; Eldemellawy MA; Xia Y; Goodale D; Allan AL; Rohani S
Eur J Pharm Biopharm; 2018 Jul; 128():156-169. PubMed ID: 29689288
[TBL] [Abstract][Full Text] [Related]
7. Inhalable particulate drug delivery systems for lung cancer therapy: Nanoparticles, microparticles, nanocomposites and nanoaggregates.
Abdelaziz HM; Gaber M; Abd-Elwakil MM; Mabrouk MT; Elgohary MM; Kamel NM; Kabary DM; Freag MS; Samaha MW; Mortada SM; Elkhodairy KA; Fang JY; Elzoghby AO
J Control Release; 2018 Jan; 269():374-392. PubMed ID: 29180168
[TBL] [Abstract][Full Text] [Related]
8. Inhalable Dual-Targeted Hybrid Lipid Nanocore-Protein Shell Composites for Combined Delivery of Genistein and All-Trans Retinoic Acid to Lung Cancer Cells.
Kamel NM; Helmy MW; Abdelfattah EZ; Khattab SN; Ragab D; Samaha MW; Fang JY; Elzoghby AO
ACS Biomater Sci Eng; 2020 Jan; 6(1):71-87. PubMed ID: 33463208
[TBL] [Abstract][Full Text] [Related]
9. Promoted Antitumor Activity of Myricetin against Lung Carcinoma Via Nanoencapsulated Phospholipid Complex in Respirable Microparticles.
Nafee N; Gaber DM; Elzoghby AO; Helmy MW; Abdallah OY
Pharm Res; 2020 Apr; 37(4):82. PubMed ID: 32291520
[TBL] [Abstract][Full Text] [Related]
10. Dual-targeted nano-in-nano albumin carriers enhance the efficacy of combined chemo/herbal therapy of lung cancer.
Elgohary MM; Helmy MW; Mortada SM; Elzoghby AO
Nanomedicine (Lond); 2018 Sep; 13(17):2221-2224. PubMed ID: 30265215
[TBL] [Abstract][Full Text] [Related]
11. Sorafenib Loaded Inhalable Polymeric Nanocarriers against Non-Small Cell Lung Cancer.
Shukla SK; Kulkarni NS; Farrales P; Kanabar DD; Parvathaneni V; Kunda NK; Muth A; Gupta V
Pharm Res; 2020 Mar; 37(3):67. PubMed ID: 32166411
[TBL] [Abstract][Full Text] [Related]
12. Delivering hydrophilic and hydrophobic chemotherapeutics simultaneously by magnetic mesoporous silica nanoparticles to inhibit cancer cells.
Liu Q; Zhang J; Sun W; Xie QR; Xia W; Gu H
Int J Nanomedicine; 2012; 7():999-1013. PubMed ID: 22403484
[TBL] [Abstract][Full Text] [Related]
13. Lactoferrin-decorated vs PEGylated zein nanospheres for combined aromatase inhibitor and herbal therapy of breast cancer.
El-Lakany SA; Elgindy NA; Helmy MW; Abu-Serie MM; Elzoghby AO
Expert Opin Drug Deliv; 2018 Sep; 15(9):835-850. PubMed ID: 30067113
[TBL] [Abstract][Full Text] [Related]
14. Multi-Reservoir Phospholipid Shell Encapsulating Protamine Nanocapsules for Co-Delivery of Letrozole and Celecoxib in Breast Cancer Therapy.
Elzoghby AO; Mostafa SK; Helmy MW; ElDemellawy MA; Sheweita SA
Pharm Res; 2017 Sep; 34(9):1956-1969. PubMed ID: 28643236
[TBL] [Abstract][Full Text] [Related]
15. Development of an inhalable, stimuli-responsive particulate system for delivery to deep lung tissue.
Abbas Y; Azzazy HM; Tammam S; Lamprecht A; Ali ME; Schmidt A; Sollazzo S; Mathur S
Colloids Surf B Biointerfaces; 2016 Oct; 146():19-30. PubMed ID: 27244047
[TBL] [Abstract][Full Text] [Related]
16. Demethoxycurcumin-carrying chitosan-antibody core-shell nanoparticles with multitherapeutic efficacy toward malignant A549 lung tumor: from in vitro characterization to in vivo evaluation.
Huang WT; Larsson M; Wang YJ; Chiou SH; Lin HY; Liu DM
Mol Pharm; 2015 Apr; 12(4):1242-9. PubMed ID: 25760774
[TBL] [Abstract][Full Text] [Related]
17. Efficient co-delivery of immiscible hydrophilic/hydrophobic chemotherapeutics by lipid emulsions for improved treatment of cancer.
Zhang B; Song Y; Wang T; Yang S; Zhang J; Liu Y; Zhang N; Garg S
Int J Nanomedicine; 2017; 12():2871-2886. PubMed ID: 28435264
[TBL] [Abstract][Full Text] [Related]
18. Preparation and properties of inhalable nanocomposite particles for treatment of lung cancer.
Tomoda K; Ohkoshi T; Hirota K; Sonavane GS; Nakajima T; Terada H; Komuro M; Kitazato K; Makino K
Colloids Surf B Biointerfaces; 2009 Jul; 71(2):177-82. PubMed ID: 19264458
[TBL] [Abstract][Full Text] [Related]
19. Anionic and Cationic Vitamin E-TPGS Mixed Polymeric Phospholipid Micellar Vehicles.
Yao M; Elbayoumi T
Methods Mol Biol; 2019; 2000():31-41. PubMed ID: 31148006
[TBL] [Abstract][Full Text] [Related]
20. Inhalable nanostructured lipid particles of 9-bromo-noscapine, a tubulin-binding cytotoxic agent: in vitro and in vivo studies.
Jyoti K; Kaur K; Pandey RS; Jain UK; Chandra R; Madan J
J Colloid Interface Sci; 2015 May; 445():219-230. PubMed ID: 25622047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
